Knowledge of the molecular architecture of CTCs is accessing novel organ specific markers that improve information regarding tumor stage, metastatic capability, progression and response to therapy.

Superficial tumors ... Biological Markers in the Diagnosis of Recurrent Bladder Cancer: An Overview - Medscape - Jan 01, 2008. Bladder cancer is considered to be one of the most common ...